National Institute of Health and Care Excellence (NICE) guidelines recommend the use of indirect comparison and network meta-analysis (NMA) when gold standard evidence from head-to-head randomised controlled trials (RCTs) is unavailable. In the third of our DRG investigative series, we assess the use of a novel method for the evidence synthesis of survival data (meta-analysis of survival curves) and determine whether this technique has been accepted by NICE.

What drives the therapy selection test market?

View Now